OvaDx may not stay with Avant after all. They f
Post# of 30028
Posted On: 05/17/2016 8:27:53 PM
OvaDx may not stay with Avant after all.
They filed the Exchange Agreement with the SEC this afternoon. It includes this:
"Agreement regarding Arrayit Corporation. On or prior to June 30, 2016, AVDX and AMBS shall have reached an agreement with Arrayit Corporation ("Arrayit"
regarding the OvaDx technology transfer, share ownership and restrictions on sales or transfer of shares of the AVDX Common Stock held, which could result in, among other things, (i) the cancellation of all agreements with Arrayit including, but not limited to, the Technology Assignment Agreement, dated July 18, 2009, share exchange agreement (ii) entry into a lockup agreement for all shares of Buyer Common Stock held by Arrayit and/or (iii) any such other agreements as the parties may agree upon on or after the Closing."
If they cancel the Technology Assignment Agreement, the rights to OvaDx go back to Arrayit.
They filed the Exchange Agreement with the SEC this afternoon. It includes this:
"Agreement regarding Arrayit Corporation. On or prior to June 30, 2016, AVDX and AMBS shall have reached an agreement with Arrayit Corporation ("Arrayit"
regarding the OvaDx technology transfer, share ownership and restrictions on sales or transfer of shares of the AVDX Common Stock held, which could result in, among other things, (i) the cancellation of all agreements with Arrayit including, but not limited to, the Technology Assignment Agreement, dated July 18, 2009, share exchange agreement (ii) entry into a lockup agreement for all shares of Buyer Common Stock held by Arrayit and/or (iii) any such other agreements as the parties may agree upon on or after the Closing." If they cancel the Technology Assignment Agreement, the rights to OvaDx go back to Arrayit.
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼